Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1) (C-Term) Peptid
RIPK1
Reaktivität: Human
BP
Sodium azide
Produktnummer ABIN1382186
Kurzübersicht für Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1) (C-Term) Peptid (ABIN1382186)
Target
RIPK1
(Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
Spezies
Human
Applikation
Blocking Peptide (BP)
-
-
Protein Region
- C-Term
-
Produktmerkmale
-
14 amino acids near the carboxy terminus of human RIP1.
Human
-
-
-
-
Applikationshinweise
- RIP1 peptide is used for blocking the activity of RIP1 antibody. It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37 °C.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 200 μg/mL
-
Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Haltbarkeit
- 12 months
-
-
- RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
Target
-
Sie sind hier:
